Zhibao Technology Inc Dossier - Source-backed chat

Zhibao Technology Inc

ZBAONASDAQ

SectorFinancials

IndustryInsurance Brokers

Beta (adjusted)1.49

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $0.10Price as of 30 Sep 2026

Data confidenceNot applicable

Market Cap $46.6M

Enterprise Value $47.7M

Shares Outstanding 466.1M diluted

Next Earnings Date31 Oct 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Zhibao Technology Inc. (NASDAQ: ZBAO) is a pioneer of the 2B2C digital embedded insurance model in China. The company has demonstrated strong top-line growth, with revenues increasing 41% year-over-year to RMB 206.0 million for the six months ended December 31, 2025, and achieving a net income turnaround of RMB 0.6 million. However, the company faces significant liquidity constraints, highlighted by a working capital deficit of RMB 30.4 million and accumulated deficits of RMB 198.2 million as of December 31, 2025. While its expansion into high-growth sectors like natural gas and sports insurance is promising, the stock remains highly volatile and speculative, justifying a Hold rating until sustainable profitability and improved liquidity are established.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.3020%

Liquidity pressures intensify due to the inability to secure additional financing or draw down on the L1 convertible notes. The remaining RMB 17.3 million payment for the Zhonglian acquisition strains cash reserves, forcing dilutive equity issuances. Increased competition in the Chinese InsurTech space compresses brokerage commission rates, pushing the company back into a net loss position.

Base CaseCentral scenario

$0.6550%

The company continues to expand its B-channel network (currently over 3,100 channels) and maintains moderate revenue growth of 25-30%. Net income remains marginally positive as higher marketing service fees offset some of the scale benefits. Liquidity is managed through existing cash balances and incremental drawdowns of convertible notes, keeping the stock trading near its current levels.

Bull CaseUpside scenario

$1.2030%

Rapid scaling of the 2B2C embedded insurance model across new verticals (e.g., low-altitude economy/drones, sports, and natural gas) drives high-margin brokerage revenue. Successful integration of the 51% stake in Zhonglian Jinan Insurance Brokers boosts overall gross margins, while the deployment of its 10 newly launched AI agents significantly reduces R&D and operational costs, leading to sustained profitability.

Scenarios reflect our research view at the research date.

Key Investment Merits

Pioneering 2B2C digital embedded insurance model with a large and growing network of over 3,100 B-channels reaching 27 million end customers.
Successful turnaround to profitability in 1H2026 (six months ended Dec 31, 2025) with net income of RMB 0.6 million.
Strong growth in specialized niches, such as natural gas insurance (nearing RMB 100 million in premiums) and sports insurance (covering 1.47 million participants in 2025).
Strategic technological upgrades, including the launch of 10 proprietary AI agents to automate workflows and code generation.

Key Investment Risks

Severe liquidity constraints, including a working capital deficit of RMB 30.4 million and accumulated deficits of RMB 198.2 million as of December 31, 2025.
High dependence on third-party B-channels for customer acquisition, which increases marketing service fees and selling expenses.
Outstanding financial obligations, including RMB 17.3 million due before October 2026 for the acquisition of Zhonglian.
Regulatory and geopolitical risks associated with operating primarily in the People's Republic of China.

Thesis Invalidation Triggers

Failure to pay the remaining installment of RMB 17.3 million for the Zhonglian acquisition, leading to legal disputes or loss of equity control.
A reversion to significant net losses in the upcoming fiscal year 2026 annual results.
Inability to access additional tranches of the L1 Securities Purchase Agreement or other financing sources, triggering a severe liquidity crisis.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.